ASGCT 2020 Abstract：Safety Evaluation of Intracerebral Injection of LentiviralABCD1 for X-ALD Gene Therapy
ASGCT 2020 Abstract：Lentiviral Gene Therapy for Hemophilia B: Exploration of Endothelial Promoters in Mesenchymal Stem Cells
ASGCT 2020 Abstract：Lentiviral Gene Therapy of Hemophilia A: Expression and Functional Comparison of Universal and Tissue-specific Promoters
The COVID-19 vaccine development landscape
Dr. Lung Ji-Chang, President of Shenzhen Genoimmune Medical Institute, in the signing ceremony of the Memorandum of Understanding (MoU) for “Technology Transfer and Application on CAR-T and Gene Therapy” at the Faculty of Medicine Siriraj Hospital
Global CAR T-Cell Therapy Market Analysis Report
GIMI 2019 GTCA
Copyright © 2016 Shenzhen Genoimmune Medical Institute all rights reserved.